Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy

BACKGROUND: Ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) differ in histopathology and prognosis. Although transendocardial delivery of mesenchymal stem cells is safe and provides cardiovascular benefits in both, a comparison of mesenchymal stem cell efficacy in ICM versus DCM has n...

Descripción completa

Detalles Bibliográficos
Autores principales: Tompkins, Bryon A., Rieger, Angela C., Florea, Victoria, Banerjee, Monisha N., Natsumeda, Makoto, Nigh, Evan D., Landin, Ana Marie, Rodriguez, Gianna M., Hatzistergos, Konstantinos E., Schulman, Ivonne Hernandez, Hare, Joshua M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064862/
https://www.ncbi.nlm.nih.gov/pubmed/30005555
http://dx.doi.org/10.1161/JAHA.117.008460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064862/
https://www.ncbi.nlm.nih.gov/pubmed/30005555
http://dx.doi.org/10.1161/JAHA.117.008460

Ejemplares similares